Market Focus

c-LEcta uses best-in-class enzyme engineering and production technologies to deliver superior biotech solutions enabling innovative industrial applications for partners in food and pharma. Our vision is to develop c-LEcta into a recognized global leader for high-performance enzymes promoting human health. The enzyme products from c-LEcta are used in many different fields, with a focus on the food and pharma industries. For example, they enable the production of active pharmaceutical substances and vaccines or can be used in the production of foods and food additives such as prebiotics or natural sweeteners. Most of the enzymes developed by c-LEcta are produced by the company itself and distributed throughout the world; a few are utilized by industry partners. Numerous innovation projects have been successfully brought to market, and many new development projects are currently under way.

c-LEcta Products for Pharma

Biotechnology expedites the journey of novel medicines, inclusive of Advanced Therapy Medicinal Products (ATMPs), from conceptualization to market availability, thereby reaching patients swiftly. These products are adept at targeting specific diseases while mitigating undesirable side effects.

Employing enzymes as biological raw materials curtails the dependency on chemical substances, engendering a more benign production of the end products.

c-LEcta’s offerings for the pharmaceutical sphere span a myriad of applications. Their enzymes are instrumental in facilitating the production of innovative therapeutic modalities, encompassing gene and cell therapy, alongside the synthesis of Active Pharmaceutical Ingredients (APIs). Their well-honed production protocols ensure the capability of manufacturing substantial quantities within a constrained timeframe.